Loading...

BioELife Corp.

LITHPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(29900.00%)
U.S. Market is Open • 15:30

BioELife Corp. (LITH) Stock Competitors & Peer Comparison

See (LITH) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LITH$0.00+29900.00%2.8KN/A-$0.22N/A
IPSEY$47.95-0.12%63.4B30.74$1.56+0.83%
MKKGY$26.10-0.87%56.5B18.57$1.40+1.93%
TKPHF$33.20-3.82%55.3B79.55$0.44+3.72%
MKGAF$126.10-4.45%55B18.01$7.02+1.50%
HLNCF$4.72-4.75%42.6B19.12$0.25+2.05%
SDZNY$79.15-2.24%34.7B38.35$2.09+0.77%
TEVJF$29.19+2.93%34B24.12$1.21N/A
SGIOF$22.63+18.48%19.3B17.96$1.26+1.97%
TAIPY$14.00+16.67%18.1B82.35$0.17N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LITH vs IPSEY Comparison April 2026

LITH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LITH stands at 2.8K. In comparison, IPSEY has a market cap of 63.4B. Regarding current trading prices, LITH is priced at $0.00, while IPSEY trades at $47.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LITH currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.74. In terms of profitability, LITH's ROE is +1.70%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, LITH and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions